Vanda Pharmaceuticals Inc.
What this means
- Net loss in 2025Net loss of $221M for the year (2024: −$18.9M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $216M | $199M |
| Net income (loss) | −$221M | −$18.9M |
| Total assets | $489M | $656M |
| Total liabilities | $162M | $118M |
| Stockholders’ equity | $327M | $539M |
| Cash and equivalents | $84.9M | $102M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Vanda Pharmaceuticals Inc.
- CIK
- 0001347178
- Tickers
- VNDA
- Kind of filer
- SEC-reporting company
Accelerated filer - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Washington, District of Columbia
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Oct 28, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Oct 29, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Oct 28, 2026 · filing
- Form 10-Q · filed Aug 6, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 5, 2026 · filing
- Form 10-Q · filed May 7, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 6, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Apr 22, 2026 · filing
- Form 8-K · items 5.02 · filed Apr 2, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Feb 19, 2026 · filing
- Form 10-K · filed Feb 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 11, 2026 · filing
- Form 10-Q · filed Oct 30, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Oct 29, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Jul 31, 2025 · filing
- Form 10-Q · filed Jul 31, 2025 · filing
- Form 10-Q · filed May 8, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 7, 2025 · filing
- Form 8-K · items 5.02 · filed Feb 20, 2025 · filing
- Form 10-K · filed Feb 14, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 13, 2025 · filing
- Form 10-Q · filed Nov 7, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 6, 2024 · filing
- Form 10-Q · filed Aug 1, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Jul 31, 2024 · filing
- Form 10-Q · filed May 9, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 8, 2024 · filing
- Form 8-K · items 5.02 · filed Feb 21, 2024 · filing
- Form 10-K · filed Feb 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 7, 2024 · filing
- Form 8-K · items 1.01, 2.01, 8.01, 9.01 · filed Dec 7, 2023 · filing
- Form 10-Q · filed Nov 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 8, 2023 · filing
- Form 10-Q · filed Jul 28, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Jul 27, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 3, 2023 · filing
- Form 10-Q · filed May 3, 2023 · filing
- Form 8-K · items 5.02, 9.01 · filed Mar 17, 2023 · filing
- Form 8-K · items 5.02 · filed Feb 17, 2023 · filing
- Form 10-K · filed Feb 9, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 8, 2023 · filing